Zitieren

[1] World Health Organization. A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products. Geneva, Switzerland: World Health Organization; 2017. Search in Google Scholar

[2] World Health Organization. WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products. Geneva, Switzerland: World Health Organization; 2017. Search in Google Scholar

[3] Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3:e002923.10.1136/bmjopen-2013-002923 Search in Google Scholar

[4] Medical Product Alert N°4/2020. Falsified Chloroquine circulating in the WHO region of Africa. World Health Organization (WHO). https://www.who.int/news-room/detail/09-04-2020-medical-product-alert-n4-2020. Search in Google Scholar

[5] Substandard and falsified medical products. World Health Organization (WHO). https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products. Published Jan. 2018. Accessed 20 May 2020. Search in Google Scholar

[6] Newton PN, Tabernero P, Dwivedi P, Culzoni MJ, Monge ME, et al. Falsified medicines in Africa: all talk, no action. Lancet. 2014;2:e509-510. https://www.thelancet.com/action/showPdf?pii=S2214-109X%2814%2970279-7. Published Sep 2014. Accessed 25 May 2020.10.1016/S2214-109X(14)70279-7 Search in Google Scholar

[7] Bate R, Jensen P, Hess K, Mooney L, Milligan J. Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis. 2013;17(3):308-311.10.5588/ijtld.12.035523321423 Search in Google Scholar

[8] Blackstone EA, Fuhr JP, Pociask MA. The Health and Economic Effects of Counterfeit Drugs. Am Health Drug Benefits. 2014;7(4):216-224. Search in Google Scholar

[9] Bekoe SO, Ahiabu M, Orman E, Tersbøl BP, Adosraku RK, et al. Exposure of consumers to substandard antibiotics from selected authorized and unauthorized medicine sales outlets in Ghana. Trop Med Int Health. 2020;25(8):962-975.10.1111/tmi.1344232418294 Search in Google Scholar

[10] Schiavetti B, Wynendaele E, De Spiegeleer B, Mbinze GJ, Kalenda N, et al. The Quality of Medicines Used in Children and Supplied by Private Pharmaceutical Wholesalers in Kinshasa, Democratic Republic of Congo: A Prospective Survey. Am J Trop Med Hyg. 2018;98(3):894-903.10.4269/ajtmh.17-0732593090929313479 Search in Google Scholar

[11] Antignac M, Diop BI, Macquart de Terline D, Bernard M, Do B, Ikama SM, et al. Fighting fake medicines: First quality evaluation of cardiac drugs in Africa. Int J Cardiol. 2017;243:523-528.10.1016/j.ijcard.2017.04.09928641892 Search in Google Scholar

[12] Schäfermann S, Hauk C, Wemakor E, Neci R, Mutombo G, et al. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and North-eastern Democratic Republic of Congo. Am J Trop Med Hyg. 2020;103(2):894-908.10.4269/ajtmh.20-0184741042732394884 Search in Google Scholar

[13] Khurelbat D, Dorj G, Sunderland B, Sanjjav T, Bayarsaikhan E, et al. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country. BMC Public Health. 2020;20:743.10.1186/s12889-020-08897-x724093432434489 Search in Google Scholar

[14] Sammons MH, Choonara I. Substandard medicines: a greater problem than counterfeit medicines? BMJ Paediatrics Open. 2017;1:e000007.10.1136/bmjpo-2017-000007584298729637090 Search in Google Scholar

[15] Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;368:1598–609.10.1056/NEJMoa121397823252499 Search in Google Scholar

[16] Abril JL, Holt DW, Wilson RR. Falsified Medicines in the European Union and North America: What are we doing to Protect Public Health? J Pharmacovigil. 2016;4:213.10.4172/2329-6887.1000213 Search in Google Scholar

[17] Loewenberg S. Combating counterfeit drugs. Lancet. 2008;371(9624):1551.10.1016/S0140-6736(08)60663-7 Search in Google Scholar

[18] Beargie SM, Higgins CR, Evans DR, Laing SK, Erim D, Ozawa S. The economic impact of substandard and falsified antimalarial medications in Nigeria. PLoS One. 2019;14(8):e0217910.10.1371/journal.pone.0217910669514831415560 Search in Google Scholar

[19] Wertheimer A, Chaney N, Santella T. Counterfeit Pharmaceuticals: Current Status and Future Projections. J Am Pharm Assoc. 2003;43(6):710-718.10.1331/15443450332264264214717268 Search in Google Scholar

[20] Schep LJ, Slaughter RJ, Temple WA, Beasley G. Diethylene glycol poisoning. Clin Toxicol. 2009;47(6):525-535.10.1080/1556365090308644419586352 Search in Google Scholar

[21] Rahman M, Yoshida N, Tsuboi H, Tomizu N, Endo J, Miyu O, Akimoto Y, Kimura K. The health consequences of falsified medicines-A study of the published literature. Trop Med Int Health. 2018;23(12):1294-1303.10.1111/tmi.1316130291683 Search in Google Scholar

[22] World Health Organisation. Growing threat from counterfeit medicines. Geneva, Switzerland: World Health Organization. 2010;88:245–246. doi:10.2471/BLT.10.010410.10.2471/BLT.10.010410 Search in Google Scholar

[23] Kelesidis T. Falagas M. Substandard/Counterfeit Antimicrobial Drugs. Clin Microbiol Rev. 2015;28(2):443-464.10.1128/CMR.00072-14440295825788516 Search in Google Scholar

[24] Lubell Y, Dondorp A, Guérin P, Drake T, Meek S, et al. Artemisinin resistance – modelling the potential human and economic costs. Malar J. 2014;13(1):452.10.1186/1475-2875-13-452425418725418416 Search in Google Scholar

[25] Wheelock A, Miraldo M, Parand A, Vincent C, Sevdalis N. Journey to vaccination: a protocol for a multinational qualitative study. BMJ Open. 2014;4(1):004279.10.1136/bmjopen-2013-004279391320524486678 Search in Google Scholar

[26] Gostin L, Buckley G, Kelley P. Stemming the Global Trade in Falsified and Substandard Medicines. JAMA. 2013;309(16):1693.10.1001/jama.2013.3048 Search in Google Scholar

[27] Ozawa S, Evans DR, Bessias S, Haynie DG, YemekeTT, et al. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low-and Middle-Income Countries. A Systematic Review and Meta-analysis. JAMA Network Open. 2018;1(4):6-10.10.1001/jamanetworkopen.2018.1662 Search in Google Scholar

[28] Przyswa E. Counterfeit Medicnes and Criminal Organisations. IRACM. 2013:14. Search in Google Scholar

[29] World Economic Forum. Global Risks 2011, Sixth Edition, An Initiative of the Risk Response Network. Geneva, Switzerland: World Economic Forum; 2011:111. Search in Google Scholar

[30] Acri, Kristina ML. Pharmaceutical Counterfeiting: Endagering Public Health, Society, and the Economy. Fraser Institute. 2018:20-36. Search in Google Scholar

[31] Aminu N, Sha’aban A, Abubakar A, Gwarzo M. Unveiling the peril of substandard and falsified medicines to public health and safety in Africa: Need for all-out war to end the menace. Med Access Point Care. 2017;1(1): e145-e154.10.5301/maapoc.0000023 Search in Google Scholar

[32] Findlay B. Counterfeit drugs and national security. Washington (DC): The Stimson Center. 2011. Search in Google Scholar

[33] Pisani E. Antimicrobial resistance: What does medicine quality have to do with it? AMR Review. 2015. URL: https://amr-review.org/sites/default/files/ElizabethPisaniMedicinesQualitypaper.pdf. Published Sep. 2015. Accessed 19 May 2020. Search in Google Scholar

[34] Buckley GJ, Gostin LO, eds. Counterfeiting the Problem of Falsified and Substandard Drugs. Washington (DC): National Academy Press (US); 2013.10.17226/18272 Search in Google Scholar

[35] Ghanem N. Substandard and Falsified Medicines: Global and Local Efforts to Address a Growing Problem. Pharm J. 2019. URL: https://www.pharmaceutical-journal.com/research/perspective-article/substandard-and-falsified-medicines-global-and-local-efforts-to-address-a-growing-problem/20206309.article?firstPass=false. Published May 2019. Accessed 23 May 2020. Search in Google Scholar

[36] Bumpass J, Bestch E. Exploratory study on active pharmaceutical ingredient manufacturing for essential medicines (English). Health, Nutrition and Population (HNP) discussion paper. Washington, DC: World Bank. 2009. URL: http://documents.worldbank.org/curated/en/848191468149087035/Exploratory-study-on-active-pharmaceutical-ingredient-manufacturing-for-essential-medicines. Accessed 26 May 2020. Search in Google Scholar

[37] Glass B. Counterfeit Drugs and Medical Devices in Developing Countries. Res Rep Trop Med. 2014;5:11-22.10.2147/RRTM.S39354 Search in Google Scholar

[38] Funestrand H, Liu R, Lundin S, Troein M. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden. Int J Public Health. 2018;41(1):e95-e102.10.1093/pubmed/fdy092 Search in Google Scholar

[39] Wiegard A, Heuermann M. The Role of the German Official Drug Investigation Bodies in Combating Counterfeit Medicines. Bundesgesundheitsbl. 2017;60:1214-1220.10.1007/s00103-017-2624-8 Search in Google Scholar

[40] Smith G, Smith JA, Brindley DA. The Falsified Medicines Directive: How to secure your supply chain. J Generic Med. 2015;11(3–4):169–172.10.1177/1741134315588986 Search in Google Scholar

[41] United States Pharmacopeia (USP) Global Public Policy Position: Combatting Substandard and Falsified Medicines. Rocksville, United States of America; 2017. URL: https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.usp.org/sites/default/files/usp/document/about/public-policy/combatting-substandard-and-falsified-medicines-policy-position.pdf&ved=2ahUKEwjestH53uPpAhUGDmMBHSIcB6MQFjAAegQICRAB&usg=AOvVaw0P4L6CkEgJ7JL963jONWp1. Published July 2017. Accessed 25 May, 2020. Search in Google Scholar

[42] Mackey TK, Liang BA, York P, Kubic T. Counterfeit Drug Penetration into Global Legitimate Medicine Supply Chains: A Global Assessment. Am J Trop Med Hyg. 2015;92(6):59-67. Doi:10.4269/ajtmh.14-0389.10.4269/ajtmh.14-0389 Search in Google Scholar

[43] Newton PN, Bond KC. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet. 2020;8(6):e754-e755.10.1016/S2214-109X(20)30136-4 Search in Google Scholar

eISSN:
2720-1961
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
Volume Open
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, Öffentliches Gesundheitswesen, Pharmazie, andere, Sozialwissenschaften, Soziologie, Allgemeines, Pädagogik